Cargando…

Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States

Detalles Bibliográficos
Autores principales: Winston, Carla A., Mitruka, Kiren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376819/
https://www.ncbi.nlm.nih.gov/pubmed/22709909
http://dx.doi.org/10.3201/eid1807.120261
_version_ 1782235876831526912
author Winston, Carla A.
Mitruka, Kiren
author_facet Winston, Carla A.
Mitruka, Kiren
author_sort Winston, Carla A.
collection PubMed
description
format Online
Article
Text
id pubmed-3376819
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33768192012-07-01 Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States Winston, Carla A. Mitruka, Kiren Emerg Infect Dis Letters to the Editor Centers for Disease Control and Prevention 2012-07 /pmc/articles/PMC3376819/ /pubmed/22709909 http://dx.doi.org/10.3201/eid1807.120261 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Letters to the Editor
Winston, Carla A.
Mitruka, Kiren
Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
title Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
title_full Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
title_fullStr Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
title_full_unstemmed Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
title_short Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
title_sort treatment duration for patients with drug-resistant tuberculosis, united states
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376819/
https://www.ncbi.nlm.nih.gov/pubmed/22709909
http://dx.doi.org/10.3201/eid1807.120261
work_keys_str_mv AT winstoncarlaa treatmentdurationforpatientswithdrugresistanttuberculosisunitedstates
AT mitrukakiren treatmentdurationforpatientswithdrugresistanttuberculosisunitedstates